Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer

Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer - Webinar

Description

Listen in to this webinar to learn more about a potential clinical trial for your patients. The RAMP 301 trial is evaluating the novel combination of avutometinib + defactinib versus investigator’s choice of therapy in patients with recurrent low grade serous ovarian cancer.

Monday, April 15 at 7:00 PM UTC (see all time zones)
Duration approximately 30 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

If you have questions or need assistance, contact education@igcs.org.

Faculty Information

Rachel Grisham, MD
Section Head Ovarian Cancer
Director, Gynecologic Medical Oncology
Memorial Sloan Kettering Cancer Center
USA

Susana Banerjee, MBBS, MA, PhD, FRCP
Consultant Medical Oncologist
Research Lead Gynaecology Unit
The Royal Marsden
UK

Supported in part by

Summary


Availability:	No future session


Cost:	FREE

Create Account

Recommended

Encouraging Results Seen in Patients with Heavily Pre-Treated Low-Grade Serous Ovarian

FREE

Emerging data in platinum resistance advanced ovarian cancer - Webinar

FREE

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions - Webinar

FREE

Preinvasive Disease Program

Preinvasive Disease Program is an IGCS member benefit.

FREE

Radical Hysterectomy - Surgical Film Festival - Webinar

$0.00 - $50.00

Multidisciplinary Approach to Treating Advanced Endometrial Cancer - Webinar

FREE

Novel combinations for treatment of recurrent cervical cancer - Webinar

Join Drs. Bradley Monk and Wendel Naumann on August 23 as they provide an overview of novel treatment options for recurrent cervical cancer, discuss combination therapy, and review recently completed clinical trials.

FREE

New Options in Platinum Resistant Ovarian Cancer - Webinar

FREE